Volitionrx Ltd (VNRX NYSE MKT) stock market data APIs
$0.6847
0.02(2.9%)
as of July 18, 2025
Try our APIs with
free plan!
Volitionrx Ltd Financial Data Overview
Price chart is built with
Anychart
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and diseases associated with NETosis such as sepsis in the United States and internationally. It offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis such as sepsis; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.
Prev. Close
0.6847
Open
0.702
High
0.7219
Low
0.6451
52 wk Range
0.3951-0.94
Market Cap
70 188 K
Shares Outstanding
104 M
Revenue
1 308 K
Beta
1.064
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Volitionrx Ltd data using free add-ons & libraries
Get Volitionrx Ltd Fundamental Data
Volitionrx Ltd Fundamental data includes:
- Net Revenue: 1 308 K
- EBITDA: -23 060 268
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-07-02
- EPS/Forecast: -0.11
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Volitionrx Ltd News
New
VolitionRx files to sell 23.44M shares of common stock by selling shareholders
* VolitionRx (NYSE:VNRX [https://seekingalpha.com/symbol/VNRX]) filed a prospectus to sale 23.44 million shares of common stock. * The company will not receive any proceeds from the sale of ordin...
VolitionRx Limited Announces Exercise of Over-Allotment Option by Underwriters
HENDERSON, Nev., June 23, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announced today that the underwriters of its previously anno...
VNRX: Highlights of Capital Markets Day (Nu.Q NETs & Nu.Q Vet); Heska being acquired by Mars (increases Nu.Q Vet distribution footprint); 13 MM share offering completed
By Steven Ralston, CFA NYSE:VNRX READ THE FULL VNRX RESEARCH REPORT Highlights of Annual Capital Markets Day On May 11, 2023, VolitionRx (NYSE:VNRX) conducted the company’s Annual Capital Market...
VolitionRx Limited Announces Closing of $16.5 Million Underwritten Public Offering of Common Stock
HENDERSON, Nev., June 5, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announced today the closing of its previously announced unde...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
